183 filings
Page 2 of 10
425
sfl6pf52rutava8if38k
30 Jan 24
Business combination disclosure
9:05am
8-K
vzp za9y75
30 Jan 24
AVROBIO and Tectonic Therapeutic Announce Merger
8:39am
RW
bgu3m2hpnerin
3 Nov 23
Registration withdrawal request
4:15pm
8-K
fibuxrvwel0ffb1vwn0
12 Jul 23
AVROBIO to Explore Strategic Alternatives
7:13am
8-K/A
nwsx2c8 0slw
14 Jun 23
Cost Associated with Exit or Disposal Activities
5:19pm
8-K
agdu2oeda
13 Jun 23
Other Events
4:41pm
8-K
8uhzb9q
12 Jun 23
Termination of a Material Definitive Agreement
7:19am
8-K
g3o kf9u53p5
9 Jun 23
Departure of Directors or Certain Officers
4:11pm
8-K
15r3m4e6
22 May 23
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
7:04am
8-K
eaae16iqqmzuls6
18 May 23
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of
7:11am
8-K
cdtuv4f
11 May 23
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update
7:20am
ARS
1w7fppotoy6mmy3
5 May 23
Annual report to shareholders
4:00pm
8-K
kaxaac63 y9u9wugf7
1 May 23
AVROBIO Announces Leadership Transition
7:40am
S-8
3w8r8r82a6q49kv7zd
23 Mar 23
Registration of securities for employees
4:58pm
8-K
6thp8h6aw397xcj
23 Mar 23
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
7:11am